PATENT CLAIM ANALYSIS

Application Number: 15896779
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "210000"]

Abstract:
The present invention discloses compounds according to Formula I: Wherein R 1 , R 2 , R 3a , R 3b , and Cy are as defined herein. The present invention relates to compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory conditions, and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis by administering a compound of the invention.

Claim (Index 19):
A method of treating and/or preventing osteoarthritis comprising administering to a subject in need thereof, the compound or pharmaceutically acceptable salt thereof according to  claim 1 .

Metadata:
- Claim Count in Document: 75.0
- Percentile: 88.0
- Lexical Diversity: 1.62264
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15538393', '16308380', '14205885', '12554611', '11958503']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7551912059288102
- 35 USC 102 Novelty (BERT): 0.5862448862492322
- Combined Prediction Score: 0.7382965739608524
- Mean Citation Score: 396.542608
- Max Citation Score: 556.40967
- Similarity Product: 375.64047523312746

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test